World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
33181
World Ranking
6078
National Ranking
592

Overview

Andrew D. Blann is a researcher affiliated with the University of Huddersfield in the United Kingdom, primarily working within the field of Medicine. Their work spans several subfields, including Infectious Diseases, Cardiology and Cardiovascular Medicine, Modeling and Simulation, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The scope of their research includes topics such as SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, COVID-19 Epidemiological Studies, Angiogenesis and VEGF in Cancer, Antiplatelet Therapy and Cardiovascular Diseases, Lipid Metabolism and Disorders, and Blood Pressure and Hypertension Studies.

Andrew D. Blann has contributed to various publication venues, notably:

  • British Journal of Biomedical Science
  • Microcirculation
  • International Journal of Laboratory Hematology
  • Oxford University Press eBooks
  • International Journal of Epidemiology and Health Sciences

Their recent papers include:

  • "SARS-CoV-2 and COVID-19: A Narrative Review," 2022, British Journal of Biomedical Science
  • "Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease," 2022, British Journal of Biomedical Science
  • "Analysis of laboratory blood parameter results for patients diagnosed with COVID-19, from all ethnic group populations: A single centre study," 2021, International Journal of Laboratory Hematology
  • "Disease of the respiratory system," 2024, Oxford University Press eBooks
  • "Retinal vascular dynamics: A window for observing an irregular heartbeat. A case report," 2024, Microcirculation

In addition to articles, Andrew D. Blann has published a book titled Biology of Disease in 2024 through Oxford University Press.

Collaborations have been a component of their research, frequently working with coauthors such as:

  • Rebekka Heitmar
  • Sukhjinder Marwah
  • Gavin Knight
  • Gary Moore
  • J. E. Brown

Best Publications

  • Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

    T. Koster;J.P. Vandenbroucke;F.R. Rosendaal;E. Briët

  • von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

    Gregory Y.H Lip;Andrew Blann

  • The adhesion molecule P-selectin and cardiovascular disease

    Andrew D Blann;Sunil K Nadar;Gregory Y H Lip

  • Platelet activation: assessment and quantification

    S. Kamath;A.D. Blann;G.Y.H. Lip

  • Circulating endothelial cells Biomarker of vascular disease

    Andrew D. Blann;Alexander Woywodt;Francesco Bertolini;Todd M. Bull

  • A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST?

    Andrew D. Blann;David A. Taberner

  • Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.

    Martin J Landray;David C Wheeler;Gregory Y.H Lip;David J Newman

  • Direct Evidence of Endothelial Injury in Acute Myocardial Infarction and Unstable Angina by Demonstration of Circulating Endothelial Cells

    Murielle Mutin;Isabelle Canavy;Andrew Blann;Michel Bory

  • Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.

    John Lekakis;Pierre Abraham;Alberto Balbarini;Andrew Blann

  • Cancer and the prothrombotic state

    Gregory Y H Lip;Bernard S P Chin;Andrew D Blann

  • Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

    Magdalena Dziadzio;Christopher P. Denton;Roy Smith;Kevin Howell

  • Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis

    Andrew D Blann;Charles N McCollum

  • ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT

    Claudio Ceconi;Kim M. Fox;William J. Remme;Marteen L. Simoons

  • Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

    B. Coleiro;S. E. Marshall;C. P. Denton;K. Howell

  • Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.

    P.K.Y. Goon;G.Y.H. Lip;C.J. Boos;P.S. Stonelake

  • Hypothesis: is soluble P-selectin a new marker of platelet activation?

    Andrew D Blann;Gregory Y.H Lip

  • Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.

    Aun Yeong Chong;Andrew D. Blann;Jeetesh Patel;Bethan Freestone

  • Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.

    Kaeng W. Lee;Gregory Y. H. Lip;Muzahir Tayebjee;William Foster

  • Circulating endothelial cells in cardiovascular disease

    Christopher J. Boos;Gregory Y.H. Lip;Andrew D. Blann

  • Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm Effects of Angiotensin-Converting Enzyme Inhibitor and β-Blocker Therapy

    Christopher R. Gibbs;Andrew D. Blann;Robert D. S. Watson;Gregory Y. H. Lip

Frequent Co-Authors

Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Charles McCollum
Charles McCollum University of Manchester
Françoise Dignat-George
Françoise Dignat-George Aix-Marseille University
Deirdre A. Lane
Deirdre A. Lane University of Liverpool
Bernd Jilma
Bernd Jilma Medical University of Vienna
Frits R. Rosendaal
Frits R. Rosendaal Leiden University Medical Center
adrian l harris
adrian l harris University of Oxford
Hans-Georg Eichler
Hans-Georg Eichler European Medicines Agency
Anthony Howell
Anthony Howell University of Manchester
Jason T. Wright
Jason T. Wright Pennsylvania State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in the medical field can accelerate your career and provide more flexible learning options. For those seeking advanced practice roles, there are now 1 year dnp program online options that help qualified nurses earn their Doctor of Nursing Practice degree faster than ever before.

If your goal is to balance clinical learning with academic requirements, consider pursuing a dnp program without clinical hours. These programs are particularly useful for experienced professionals looking for academic advancement without additional hands-on training.

For those aiming to enter the workforce quickly, understanding what is the fastest way to become an lpn can be crucial. Fast-track Licensed Practical Nurse (LPN) programs offer rapid routes into patient care roles and often fit around other commitments.

Mental health professionals are also in high demand, and you can pursue a fast track mental health nursing program to qualify as a Psychiatric Mental Health Nurse Practitioner (PMHNP) online in less time than traditional routes.

Best Scientists Citing Andrew D. Blann

Trending Scientists